Patient videos for those about to start immunotherapy
February 2019 A group of researchers at Peter Mac have spent the past year working with patients, family members, nurses and medical oncologists to develop a series of videos for…
Read More Publications
Melanoma Journal Articles for February 2019
JCI insight MicroRNA-155 coordinates the immunological landscape within murine melanoma and correlates with immunity in human cancers H. Atakan Ekiz, Thomas B. Huffaker, Allie H. Grossmann, W. Zac Stephens, Matthew A. Williams, June L. Round,…
Read More Merck gets FDA nod for Keytruda as adjuvant treatment for melanoma
Source: Pharmaceutical Business Review, March 2019 Merck has secured approval from the US Food and Drug Administration (FDA) for its Keytruda (pembrolizumab) as the adjuvant treatment for patients with melanoma…
Read More FDA Approves Keytruda for Melanoma Patients After Tumor Resection
Source: Immuno-Oncology News, March 2019 The U.S. Food and Drug Administration has approved the use of Keytruda(pembrolizumab) as a treatment for melanoma patients with stage 3 disease — cancer cells have…
Read More